GUERRA LUCA

Durmo, R., Chauvie, S., Minoia, C., Bergesio, F., Fallanca, F., Peano, S., et al. (2025). Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial. AMERICAN JOURNAL OF HEMATOLOGY, 100(7), 1196-1204 [10.1002/ajh.27711]. Dettaglio

Durmo, R., Chauvie, S., Fallanca, F., Bergesio, F., Pinto, A., Del Giudice, I., et al. (2025). Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi. BLOOD ADVANCES, 9(12), 2927-2934 [10.1182/bloodadvances.2024014790]. Dettaglio

Monaco, L., Crivellaro, C., De Bernardi, E., Bono, F., Casati, G., Seminati, D., et al. (2025). Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 19 [10.1177/17534666251384433]. Dettaglio

Guerra, L., Albano, D. (2025). Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma?. THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING [10.23736/s1824-4785.25.03657-x]. Dettaglio

Guerra, L., Chauvie, S., Fallanca, F., Bergesio, F., Marcheselli, L., Durmo, R., et al. (2024). End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 51(11), 3311-3321 [10.1007/s00259-024-06765-z]. Dettaglio